Frailty Is Associated With Mortality and Incident Comorbidity Among Middle-Aged Human Immunodeficiency Virus (HIV)–Positive and HIV-Negative Participants

人类免疫缺陷病毒(HIV) 共病 医学 病毒学 免疫学 老年学 精神科
作者
Eveline Verheij,Gregory Dale Kirk,Ferdinand W.N.M. Wit,Rosan A van Zoest,Sebastiaan O Verboeket,Bregtje A. Lemkes,Maarten F. Schim van der Loeff,Peter Reiss,for the AGEhIV Cohort
出处
期刊:The Journal of Infectious Diseases [Oxford University Press]
卷期号:222 (6): 919-928 被引量:55
标识
DOI:10.1093/infdis/jiaa010
摘要

BACKGROUND: Frailty is associated with mortality and morbidity in the general geriatric population, but less is known about its impact among the aging but generally younger population with human immunodeficiency virus (HIV). METHODS: The impact of frailty on all-cause mortality during 6 years of follow-up and incident comorbidity during 4 years of follow-up was assessed among 598 HIV-positive and 550 comparable HIV-negative participants aged ≥ 45 years of the AGEhIV Cohort Study. Frailty encompasses 5 domains; weight loss, low physical activity, exhaustion, decreased grip strength, and slow gait speed. Presence of ≥ 3 denotes frailty, 1-2 prefrailty, and 0 robust. Multivariable Cox and logistic regression models were used to assess the independent relationships of frailty with both outcomes, adjusting for HIV infection and traditional risk factors. RESULTS: At baseline, 7.5% (n = 86) of participants were frail. During follow-up, 38 participants died. Mortality rate was significantly higher among frail participants: 25.7/1000 person-years of follow-up (PYFU) (95% confidence interval [CI], 14.2-46.4) compared with prefrail (7.2/1000 PYFU [95% CI, 4.7-11.2]) and robust (2.3/1000 PYFU [95% CI, 1.1-4.9]). In fully adjusted analyses, frailty remained strongly associated with death (hazard ratio, 4.6 [95% CI, 1.7-12.5]) and incident comorbidity (odds ratio, 1.9 [95% CI, 1.1-3.1]). No interactions were observed between frailty and HIV status in all analyses. CONCLUSIONS: Frailty is a strong predictor of both mortality and incident comorbidity independent from other risk factors. CLINICAL TRIALS REGISTRATION: NCT01466582.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
复嘟嘟完成签到,获得积分10
1秒前
Nole的应助被观的采纳,获得30
1秒前
DW的应助被瑞达采纳,获得10
1秒前
搜集达人的应助被张顺采纳,获得10
1秒前
义气的哈密瓜完成签到,获得积分10
2秒前
搜集达人的应助被Hello_Alina采纳,获得10
2秒前
小黄发布了新的文献求助10
2秒前
Celeste完成签到 ,获得积分10
2秒前
kipo完成签到 ,获得积分10
2秒前
王十七发布了新的文献求助10
2秒前
3秒前
wanci的应助被爽朗的小王同学采纳,获得10
3秒前
瓶子完成签到 ,获得积分10
3秒前
甜美无剑发布了新的文献求助10
3秒前
李健的小迷弟的应助被youyyuy采纳,获得10
4秒前
5秒前
彳亍完成签到,获得积分10
5秒前
6秒前
斯文败类的应助被王新涛采纳,获得10
6秒前
6秒前
2339822272发布了新的文献求助10
6秒前
我是谁的应助被小胖采纳,获得30
7秒前
充电宝的应助被云晓采纳,获得10
8秒前
充电宝的应助被阿楠采纳,获得10
8秒前
yyt完成签到 ,获得积分10
8秒前
爆米花的应助被dan1029采纳,获得10
8秒前
Hello的应助被dan1029采纳,获得10
8秒前
李爱国的应助被dan1029采纳,获得10
8秒前
CodeCraft的应助被dan1029采纳,获得10
8秒前
8秒前
小蘑菇的应助被dan1029采纳,获得10
8秒前
8秒前
万能图书馆的应助被dan1029采纳,获得10
8秒前
Akim的应助被dan1029采纳,获得10
9秒前
sss完成签到 ,获得积分10
9秒前
李健的应助被dan1029采纳,获得10
9秒前
斯文雁易完成签到,获得积分10
9秒前
爆米花的应助被dan1029采纳,获得10
9秒前
04d的应助被dan1029采纳,获得10
9秒前
9秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8180713
求助须知:如何正确求助?哪些是违规求助? 9570752
关于积分的说明 21814119
捐赠科研通 7776960
什么是DOI,文献DOI怎么找? 3433298
关于科研通互助平台的介绍 2557579
邀请新用户注册赠送积分活动 2479287